Intellia Therapeutics (NTLA) Operating Margin Growth (1y) (2016 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3,609.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1,536.00
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -170.00
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -3,724.00
10 Intellia Therapeutics 1.63 Bn 1.63 Bn - 5,850.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5,850.00
Dec 31, 2025 63,101.00
Sep 30, 2025 78,010.00
Jun 30, 2025 122,643.00
Mar 31, 2025 -33,257.00
Dec 31, 2024 -835,731.00
Sep 30, 2024 -49,567.00
Jun 30, 2024 -102,513.00
Mar 31, 2024 49,414.00
Dec 31, 2023 810,852.00
Sep 30, 2023 -29,779.00
Jun 30, 2023 -27,282.00
Mar 31, 2023 39,383.00
Dec 31, 2022 -18,547.00
Sep 30, 2022 2.32 Mn
Jun 30, 2022 35,305.00
Mar 31, 2022 -56,163.00
Dec 31, 2021 1,729.00
Sep 30, 2021 -2.39 Mn
Jun 30, 2021 -85,057.00
Mar 31, 2021 -5,937.00
Dec 31, 2020 -37,067.00
Sep 30, 2020 11,211.00
Jun 30, 2020 4,386.00
Mar 31, 2020 -43,275.00
Dec 31, 2019 -896.00
Sep 30, 2019 8,673.00
Jun 30, 2019 6,036.00
Mar 31, 2019 7,210.00
Dec 31, 2018 10,738.00
Sep 30, 2018 -10,835.00
Jun 30, 2018 -3,665.00
Mar 31, 2018 -9,197.00
Dec 31, 2017 -17,833.00
Sep 30, 2017 -5,888.00
Jun 30, 2017 -10,555.00
Mar 31, 2017 16,837.00
Dec 31, 2016 13,201.00
Sep 30, 2016 3,748.00
Jun 30, 2016 8,337.00
Mar 31, 2016 -28,378.00